Holen Sie sich die Stockscreener-App
0.3601
2.86%
0.010
Handel nachbörslich:
.35
-0.0101
-2.80%
Schlusskurs vom Vortag:
$0.3501
Offen:
$0.36
24-Stunden-Volumen:
349.28K
Relative Volume:
1.37
Marktkapitalisierung:
$8.40M
Einnahmen:
$81.89M
Nettoeinkommen (Verlust:
$-55.20M
KGV:
-0.1336
EPS:
-2.6959
Netto-Cashflow:
$-67.40M
1W Leistung:
-0.80%
1M Leistung:
+15.16%
6M Leistung:
-33.00%
1J Leistung:
-84.41%
1-Tages-Spanne:
$0.3519
$0.3695
1-Wochen-Bereich:
$0.3301
$0.3774
52-Wochen-Spanne:
$0.29
$2.69
Turnstone Biologics Corp Stock (TSBX) Company Profile
Firmenname
Turnstone Biologics Corp
Sektor
Branche
Telefon
347-897-5988
Adresse
9310 ATHENA CIRCLE, SUITE 300, LA JOLLA
Vergleichen Sie TSBX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TSBX
Turnstone Biologics Corp
|
0.3601 | 8.40M | 81.89M | -55.20M | -67.40M | -2.6959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Turnstone Biologics Corp Stock (TSBX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-08-16 | Eingeleitet | SVB Securities | Market Perform |
| 2023-08-15 | Eingeleitet | BofA Securities | Buy |
| 2023-08-15 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Turnstone Biologics Corp Aktie (TSBX) Neueste Nachrichten
Millennium Management LLC Cuts Position in Turnstone Biologics Corp. (NASDAQ:TSBX) - Defense World
Atara Biotherapeutics (NASDAQ:ATRA) & Turnstone Biologics (NASDAQ:TSBX) Financial Analysis - Defense World
Check out Turnstone Biologics Corp's stock price (TSBX) in real time - CNBC
Turnstone Biologics Reports Q1 Loss Amid Strategic Shift - TipRanks
Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights - The Manila Times
Turnstone Biologics Reports Q1 2025 Financial Results and Updates on Strategic Alternatives - Nasdaq
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent - Bluefield Daily Telegraph
Turnstone Biologics (NASDAQ:TSBX) Shares Up 0.8% – Still a Buy? - Defense World
Turnstone Biologics stock plunges to 52-week low of $0.29 By Investing.com - Investing.com South Africa
Turnstone Biologics stock plunges to 52-week low of $0.29 - Investing.com Australia
Turnstone Biologics stock plunges to 52-week low of $0.33 By Investing.com - Investing.com South Africa
Turnstone Biologics stock plunges to 52-week low of $0.33 - Investing.com
Turnstone Biologics stock plunges to 52-week low of $0.34 By Investing.com - Investing.com South Africa
Turnstone Biologics stock plunges to 52-week low of $0.34 - Investing.com
Q1 EPS Forecast for Turnstone Biologics Decreased by Analyst - Defense World
Analysts Set Expectations for TSBX Q1 Earnings - Defense World
Turnstone Biologics Corp: Strategic Partnerships and Financial Position Justify Hold Rating - TipRanks
Turnstone Biologics Reports 2024 Financial Results - TipRanks
Turnstone Biologics moves to Nasdaq Capital Market By Investing.com - Investing.com South Africa
Turnstone Biologics moves to Nasdaq Capital Market - Investing.com
Turnstone Biologics Corp. SEC 10-K Report - TradingView
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Turnstone Biologics Cuts Losses by $3.6M as Company Pivots Strategy - Stock Titan
Turnstone Biologics Corp. (NASDAQ:TSBX) Sees Significant Growth in Short Interest - Defense World
Turnstone Biologics (TSBX) Expected to Announce Earnings on Thursday - Defense World
Turnstone Biologics stock plunges to 52-week low of $0.35 By Investing.com - Investing.com Australia
Turnstone Biologics stock plunges to 52-week low of $0.35 - Investing.com India
Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering, Business Wires News - AsiaOne
Turnstone Biologics Corp. (NASDAQ:TSBX) Sees Large Drop in Short Interest - Defense World
Turnstone Biologics Stock Hits 52-Week Low at $0.36 Amid Challenges - Investing.com Australia
Turnstone Biologics halts TIDAL-01 development, seeks alternatives - MSN
Turnstone Biologics stock plunges to 52-week low of $0.4 - MSN
Turnstone Biologics stock plunges to 52-week low of $0.4 By Investing.com - Investing.com Canada
Cautious Hold on Turnstone Biologics Amid TIL Therapy Challenges and Strategic Alternatives - TipRanks
Analysts Offer Predictions for TSBX FY2024 Earnings - Defense World
Turnstone Biologics Corp. (TSBX) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Finanzdaten der Turnstone Biologics Corp-Aktie (TSBX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):